胰十二指腸切除術在胰頭癌治療中的應用與進展_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

柯能文 ,  劉續寶

四川大學華西醫院胰腺外科（成都 610041）;

Corresponding?author：

劉續寶, Email: xbliu@medmail.com.cn

Keywords：

DOI：

10.7507/1007-9424.201903015

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 柯能文, 劉續寶. 胰十二指腸切除術在胰頭癌治療中的應用與進展. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(4): 385-388. doi: 10.7507/1007-9424.201903015 Copy

1.	Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin, 2001, 51(1): 15-36.
2.	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
3.	Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014, 74(11): 2913-2921.
4.	Huang L, Jansen L, Balavarca Y, et al. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med, 2018, 16(1): 125-140.
5.	Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 2004, 350(12): 1200-1210.
6.	Schnelldorfer T, Sarr MG. Alessandro codivilla and the first pancreatoduodenectomy. Arch Surg, 2009, 144(12): 1179-1184.
7.	Sauvé L. Des pancréatectomies et spécialement de la pancréatectomie céphalique [on pancreatectomies and in particular on pancreatectomy of the head]. Rev Chir, 1908, 37: 113-385.
8.	Desjardins A. Technique de la pancréatectomie. Rev Chir, 1907, 35: 945-973.
9.	Kausch W. Das carcinom der papilla duodeni und seine radikale entfernung. Beitr Klin Chir, 1912, 78: 439-86.
10.	Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of vater. Ann Surg, 1935, 102(4): 763-779.
11.	Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet, 1946, 82: 623-631.
12.	Whipple AO. A reminiscence: pancreaticduodenectomy. Rev Surg, 1963, 20: 221-225.
13.	Watson K. Carcinoma of ampulla of vater successful radical resection. Br J Surg, 1944, 31: 368-373.
14.	Lillemoe KD, Rikkers LF. Pancreaticoduodenectomy: the golden era. Ann Surg, 2006, 244(1): 16-17.
15.	Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg, 1995, 221(2): 133-148.
16.	Gordon TA, Bowman HM, Tielsch JM, et al. Statewide regio-nalization of pancreaticoduodenectomy and its effect onin-hospital mortality. Ann Surg, 1998, 228(1): 71-78.
17.	Shrikhande SV, Sivasanker M, Vollmer CM, et al. Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 2017, 161(5): 1221-1234.
18.	Chen Y, Tan C, Zhang H, et al. Novel entirely continuous running suture of two-layer pancreaticojejunostomy using only one polypropylene monofilament suture. J Am Coll Surg, 2013, 216(2): e17-e21.
19.	Washington K, Berlin J, Branton Ph, et al. Protocol for the examination of specimens from patients with carcinoma of the pancreas. 2017-06. http://www.cap.org.
20.	The Royal College of Pathologists. London. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. 2017-03. http://www.rcpath.org.
21.	NCCN. NCCN Clinical Practice Guidelines in oncology: pancreatic adenocacinomar, Version 1. 2019. 2018-12. http://www.nccn.org.
22.	Strobel O, Hank T, Hinz U, et al. Pancreatic cancer surgery: the new r-status counts. Ann Surg, 2017, 265(3): 565-573.
23.	Delpero JR, Jeune F, Bachellier P, et al. Prognostic value of resection margin involvement after pancreaticoduodenectomy for ductal adenocarcinoma: updates from a French Prospective Multicenter Study. Ann Surg, 2017, 266(5): 787-796.
24.	木村理. 胰脾外科要點與盲點. 北京: 人民衛生出版社, 2010: 148.
25.	Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg, 2014, 259(4): 656-664.
26.	Hackert T, Sachsenmaier M, Hinz U, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg, 2016, 264(3): 457-463.
27.	Michelakos T, Pergolini I, Castillo CF, et al. Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX. Ann Surg, 2019, 269(4): 733-740.
28.	Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol, 2009, 16(7): 1736-1744.
29.	Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg, 2009, 75(9): 804-809.
30.	Tang D, Zhang JQ, Wang DR. Long term results of pancreatectomy with portal-superior mesenteric vein resection for pancreatic carcinoma: a systematic review. Hepatogastroenterology, 2011, 58(106): 623-631.
31.	Gagner M, Pomp A. Laparoscopic pylorus-preserving panc-reatoduodenectomy. Surg Endosc, 1994, 8(5): 408-410.
32.	Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg, 2003, 138(7): 777-784.
33.	Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, et al. Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. J Am Coll Surg, 2014, 218(1): 129-139.

1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin, 2001, 51(1): 15-36.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
3. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014, 74(11): 2913-2921.
4. Huang L, Jansen L, Balavarca Y, et al. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med, 2018, 16(1): 125-140.
5. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 2004, 350(12): 1200-1210.
6. Schnelldorfer T, Sarr MG. Alessandro codivilla and the first pancreatoduodenectomy. Arch Surg, 2009, 144(12): 1179-1184.
7. Sauvé L. Des pancréatectomies et spécialement de la pancréatectomie céphalique [on pancreatectomies and in particular on pancreatectomy of the head]. Rev Chir, 1908, 37: 113-385.
8. Desjardins A. Technique de la pancréatectomie. Rev Chir, 1907, 35: 945-973.
9. Kausch W. Das carcinom der papilla duodeni und seine radikale entfernung. Beitr Klin Chir, 1912, 78: 439-86.
10. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of vater. Ann Surg, 1935, 102(4): 763-779.
11. Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet, 1946, 82: 623-631.
12. Whipple AO. A reminiscence: pancreaticduodenectomy. Rev Surg, 1963, 20: 221-225.
13. Watson K. Carcinoma of ampulla of vater successful radical resection. Br J Surg, 1944, 31: 368-373.
14. Lillemoe KD, Rikkers LF. Pancreaticoduodenectomy: the golden era. Ann Surg, 2006, 244(1): 16-17.
15. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg, 1995, 221(2): 133-148.
16. Gordon TA, Bowman HM, Tielsch JM, et al. Statewide regio-nalization of pancreaticoduodenectomy and its effect onin-hospital mortality. Ann Surg, 1998, 228(1): 71-78.
17. Shrikhande SV, Sivasanker M, Vollmer CM, et al. Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 2017, 161(5): 1221-1234.
18. Chen Y, Tan C, Zhang H, et al. Novel entirely continuous running suture of two-layer pancreaticojejunostomy using only one polypropylene monofilament suture. J Am Coll Surg, 2013, 216(2): e17-e21.
19. Washington K, Berlin J, Branton Ph, et al. Protocol for the examination of specimens from patients with carcinoma of the pancreas. 2017-06. http://www.cap.org.
20. The Royal College of Pathologists. London. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. 2017-03. http://www.rcpath.org.
21. NCCN. NCCN Clinical Practice Guidelines in oncology: pancreatic adenocacinomar, Version 1. 2019. 2018-12. http://www.nccn.org.
22. Strobel O, Hank T, Hinz U, et al. Pancreatic cancer surgery: the new r-status counts. Ann Surg, 2017, 265(3): 565-573.
23. Delpero JR, Jeune F, Bachellier P, et al. Prognostic value of resection margin involvement after pancreaticoduodenectomy for ductal adenocarcinoma: updates from a French Prospective Multicenter Study. Ann Surg, 2017, 266(5): 787-796.
24. 木村理. 胰脾外科要點與盲點. 北京: 人民衛生出版社, 2010: 148.
25. Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg, 2014, 259(4): 656-664.
26. Hackert T, Sachsenmaier M, Hinz U, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg, 2016, 264(3): 457-463.
27. Michelakos T, Pergolini I, Castillo CF, et al. Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX. Ann Surg, 2019, 269(4): 733-740.
28. Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol, 2009, 16(7): 1736-1744.
29. Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg, 2009, 75(9): 804-809.
30. Tang D, Zhang JQ, Wang DR. Long term results of pancreatectomy with portal-superior mesenteric vein resection for pancreatic carcinoma: a systematic review. Hepatogastroenterology, 2011, 58(106): 623-631.
31. Gagner M, Pomp A. Laparoscopic pylorus-preserving panc-reatoduodenectomy. Surg Endosc, 1994, 8(5): 408-410.
32. Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg, 2003, 138(7): 777-784.
33. Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, et al. Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. J Am Coll Surg, 2014, 218(1): 129-139.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

胰十二指腸切除術在胰頭癌治療中的應用與進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content